Results 181 to 190 of about 10,825 (231)
Brain, Behavior, and Immunity, 2012 A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated ...
Trevor A Day +2 more
exaly +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
SNRIs: mechanism of action and clinical features
Expert Review of Neurotherapeutics, 2002Specific serotonin and norepinephrine reuptake inhibitors are a relatively recent class of antidepressants which have specificities making them a therapeutic choice. They are characterized by a mixed action on both major neuroamines of depression: norepinephrine and serotonin.
Olivier, Lambert, Michel, Bourin
openaire +2 more sources
A review of SSRIs and SNRIs in neuropathic pain
Expert Opinion on Pharmacotherapy, 2010Selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenaline reuptake inhibitors (SNRIs) are becoming increasingly used in the treatment of neuropathic pain and fibromyalgia. However, they are not without adverse effects and their efficacy has not been clear because of conflicting evidence.We have examined the current evidence on the ...
Yee-Chi, Lee, Phoon-Ping, Chen
openaire +2 more sources
The anti-inflammatory mechanism of antidepressants – SSRIs, SNRIs
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2018The cytokine theory of depression no longer brings about any doubts. Experiments and research studies conducted in the last ten years have confirmed that both physical and psychological (emotional) stress increases the likelihood of occurrence of mental disorders (including depressive disorders) owing to the action of a series of hormonal and ...
Piotr, Gałecki +2 more
openaire +2 more sources
Fatal overdose with a combination of SNRIs venlafaxine and duloxetine
Forensic Science, Medicine and Pathology, 2019Drugs for the treatment of depressive disorders, including SNRIs (serotonin noradrenaline reuptake inhibitors) venlafaxine and duloxetine, are widely prescribed as they have a high therapeutic to toxicity ratio. In rare cases, adverse effects may be severe, usually due to iatrogenic, accidental or intentional self-overdose that cause the excessive ...
Armin, Alibegović +2 more
openaire +2 more sources
Effect of SSRIs and SNRIs on Nocturnal Urinary Frequency
Annals of Pharmacotherapy, 2016Background: Existing data suggest that selective serotonin uptake inhibitors (SSRIs) may have an impact on urinary frequency. Objective: To evaluate the impact of SSRIs and selective noradrenaline reuptake inhibitors (SNRIs) on nocturnal urinary frequency.
Boris I, Medarov +4 more
openaire +2 more sources
A Newly Released SNRI for Treatment of Fibromyalgia
Current Psychiatry Reports, 2010Milnacipran is a dual norepinephrine and serotonin reuptake inhibitor (SNRI) that was recently approved by the US Food and Drug Administration for the treatment of fibromyalgia (FM). SNRIs are frequently used, along with graded exercise and cognitive-behavioral therapy, to treat FM.
openaire +2 more sources
Placental Transfer of SSRI and SNRI Antidepressants and Effects on the Neonate
Pharmacopsychiatry, 2009We investigated placental transfer and neurobehavioural effects in neonates exposed to citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine or sertraline (SSRI's), or to venlafaxine (an SNRI).Women receiving antidepressants during pregnancy and their neonates were studied. Cord and maternal drug concentrations were measured at birth and in the
K F Ilett
exaly +3 more sources
Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression
JAMA PsychiatryImportanceTreatment-resistant depression (TRD) remains a critical challenge in psychiatry, with limited effective options. Esketamine, a rapid-acting antidepressant, is usually combined with a selective serotonin reuptake inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI), but comparative evidence of these combinations ...
Giovanna Gentile +2 more
exaly +4 more sources
Treating Depression with SNRIs: Who Will Benefit Most?
CNS Spectrums, 2008AbstractThere is evidence that the serotonin norepinephrine reuptake inhibitors (SNRIs) venlafaxine, milnacipran, and duloxetine, have probable superior antidepressant activity to most selective serotonin reuptake inhibitors (SSRIs), especially in more severe depression. Some patients, however, respond better than others to SNRIs.
openaire +2 more sources